In Canada, Nexelis, a Q² Solutions Company, emerged from a GSK spin out as NEOMED-LABS with extensive knowledge and a pharma mindset. In the United States, we grew from a University of Washington research unit to earn wide respect as Pacific Biomarkers. In Europe, we expanded our clinical bioanalytical services with the acquisition of GSK Marburg.
Uitgesoekte Werk
Verwante Maatskappye
Ander Hulpbronne